Previous 10 | Next 10 |
2024-02-13 10:39:02 ET Organigram Holdings Inc. (OGI) Q1 2024 Earnings Conference Call February 13, 2024, 08:00 AM ET Company Participants Max Schwartz - Director, IR Beena Goldenberg - CEO Greg Guyatt - CFO Conference Call Participants Aaron Grey - A...
2024-02-13 06:03:44 ET More on Organigram Holdings Why Organigram Is My Favorite Cannabis Stock Organigram's Bold Leap Forward: Unpacking The Impact Of BAT's Game-Changing Investment Organigram: Structural Issues In Canada Remain Seeking Alpha’s Quant ...
ESSA Pharma Inc. (EPIX) is expected to report $-0.17 for Q1 2024 QuidelOrtho Corp Com (QDEL) is expected to report $2.01 for Q4 2023 FaZe Holdings Inc. (FAZE) is expected to report for Q4 2023 Portsmouth Square, Inc. (PRSI) is expected to report for Q2 2024 Similarweb Ltd. (SMWB) ...
Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers, significantly improved margins sequentially quarter-over-quarter, and closed first $41.5 million tranche of previously announced $124.6 million investment from BAT HIGHLIGHTS ...
2024-02-12 11:40:18 ET More on Organigram Holdings Why Organigram Is My Favorite Cannabis Stock Organigram's Bold Leap Forward: Unpacking The Impact Of BAT's Game-Changing Investment Organigram: Structural Issues In Canada Remain Read the full article on Se...
2024-02-10 18:25:10 ET Top Performer’s Surge in the Cannabis Sector In February 2024, top Canadian cannabis stocks showed mixed performance amid evolving market dynamics. Companies like Canopy Growth, Aurora Cannabis, and Tilray Brands remained focal points for investors. Mar...
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
2024-02-07 12:07:38 ET More on U.S. MSOs Alan Brochstein On Rescheduling Overexcitement, MSOs, Canada And The Burden Of 280E Curaleaf Is A Bad Cannabis Investment Cresco Labs At The Crossroads: Strategic Agility In A Transforming Cannabis Landscape Cresco Lab...
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December...
2024-02-06 12:25:57 ET More on cannabis ETFs MSOS: Investors Should Exit This ETF MSOS: Cannabis Sector Consolidating Under The Radar, Looking Constructive (Technical Analysis) Cannabis Investors - What You Should Know Cannabis companies higher after Biden pa...
News, Short Squeeze, Breakout and More Instantly...
Organigram Holdings Inc. Company Name:
OGI Stock Symbol:
NYSE Market:
Organigram Holdings Inc. Website:
Second “Jupiter” investment strengthens Organigram’s European access, including to the high-growth market of Germany Highlights: Concurrent to the investment, Organigram and Sanity Group have entered into a new supply agreement to include significantly higher ...
Over a three-year period, Organigram expects to supply 1,700 kilograms of high-quality medical cannabis flower to Avida Medical, with 500 kilograms expected to be delivered in the first year of the agreement. Avida Medical to become Organigram’s second international medical cannabis cu...
2024-05-21 09:00:20 ET Key Canadian Cannabis Stocks to Watch Today As Memorial Day weekend approaches, investors are eyeing top Canadian marijuana stocks . These stocks have shown potential for significant growth. The global cannabis industry is expected to be worth over $73 billion...